glp 1 and osa Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Sleep Apnea Syndrome Management: A Narrative Review GLP-1 medications for sleep apnea:

Back Molteni, M (17 Oct 2023) 'How one scientist's determination made Novo Nordisk an obesity-drug powerhouse', STAT News

95% CI: 0.981.39)

Each ingredient was selected for synergistic effects from appetite regulation and fat burning to mental balance during weight loss

GLP-1 drugs show promise for weight management Across the reviews, tirzepatide, semaglutide, and liraglutide each led to significant weight loss compared to placebo after one to two years, with these effects likely to be sustained while treatment continues

HbA1c Targets 48 mmol/mol (6.5%) for individuals not at risk of hypoglycaemia 53 mmol/mol (7.0%) for those on therapies associated with hypoglycaemia Intensification is recommended if HbA1c rises to 58 mmol/mol (7.5%) Targets may be relaxed in older or frail individuals where risks outweigh long-term benefits

ISSN 1060-4332